SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?


To: Mike McFarland who wrote (184)3/17/2005 6:51:36 PM
From: Mike McFarland  Respond to of 360
 
The Company expects its cash position to be approximately
$70 to $75 million by the end of 2005 and that it will be
generating cash in 2007.
..................
Have not listened to CC, and probably wont get
a chance til Sunday. Looks like I will be holding
this for awhile. Not crazy about this guesstimate
that they will turn a profit in 2007. It will be
an awfully long wait in '06 for that, and they'll
be burning all the way. On the other hand, if
they pull it off, this will probably be trading
around 1x sales if it maintains the current marketcap.

I think the whole thing will hinge on 2006, either
there will be a trend toward profitability next
year, or they will be burning through their cash
in '06 in order to make a profit in '07.

I think I'd rather they just got bought out now.
Geeze, I even offered up the new name on the
Yahoo board: Perlogic. I didn't get one comment
back, naturally.



To: Mike McFarland who wrote (184)3/24/2005 7:01:51 PM
From: Mike McFarland  Read Replies (2) | Respond to of 360
 
Toxicogenomics Data: The Road to Acceptance
ehp.niehs.nih.gov
(Iconix, Gene Logic mentioned)

Phenotypic anchoring
ehp.niehs.nih.gov

Molecular biomarkers in drug development
pharmadiscovery2005.com

Predictive toxicology meeting last September
barnettinternational.com